Effects of medication management with clinical pharmacists' participation on medication standardization, compliance, and safety in patients with acute cerebral infarction after intervention

doi:10.3760/cma.j.issn.1007-1245.2023.04.028

Abstract

Abstract:

Objective　To investigate the effects of medication management with clinical pharmacists' participation on medication standardization, compliance, and safety in patients with acute cerebral infarction after intervention. Methods　A total of 50 patients with acute cerebral infarction who underwent intervention in Liaocheng Third People's Hospital from February 2020 to February 2022 were selected for the random control trial, including 33 males and 17 females who were (66.16±7.85) years old. They were divided into a control group and an observation group by the random number table method, with 25 cases in each group. The control group received routine medication management and health education after operation; in addition, the observation group received medication management with clinical pharmacists' participation. The rational drug use indicators (hospital stay, hospitalization expense, and medication expense) were recorded. The medication standardization and medication compliances of the two groups were compared before and 3 months after the intervention. The safety and satisfaction were evaluated. t test, analysis of variance, and χ² test were applied. Results　The hospital stay, hospitalization expense, and medication expense of the observation group were lower than those of the control group [(13.45±3.68) d vs. (15.96±4.01) d, (5 125.44±335.71) yuan vs. (5 543.75±340.94) yuan, and (1 483.55±368.94) yuan vs. (1 876.43±377.56) yuan], with statistical differences (t=2.306, 4.371, and 3.721; all P<0.05). After the intervention, the incidence of irrational drug use and medication compliance rate in the observation group were better than those in the control group [16.00% (4/25) vs. 44.00% (11/25) and 96.00% (24/25) vs. 72.00% (18/25)], with statistical differences (both P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group [12.00 % (3/25) vs. 36.00 % (9/25)] and the nursing satisfaction in the observation group was higher than that in the control group [96.00 % (24/25) vs. 76.00 % (19/25)], with statistical differences (χ²=3.947 and 4.153; both P<0.05). Conclusion　Medication management with clinical pharmacists' participation for patients with acute cerebral infarction after intervention can not only improve the clinical drug management system, enhance medication effect, and reduce irrational drug use, but also improve the patients' medication compliance and nursing satisfaction and reduce adverse reactions.

Key words:

Acute cerebral infarction, Medication management with clinical pharmacists' participation, Intervention, Medication standardization, Medication compliance, Safety

摘要：

目的　探讨临床药师参与的用药管理对急性脑梗死介入术后患者用药规范性、用药依从性及安全性的影响。方法　选取2020年2月至2022年2月于聊城市第三人民医院接受介入术治疗的50例急性脑梗死患者进行随机对照试验，男性33例，女性17例，年龄（66.16±7.85）岁。采用随机数字表法将其分为对照组和观察组，各25例。对照组患者术后给予常规用药管理及健康宣教，观察组在以上基础给予临床药师参与的用药管理。记录两组合理用药指标（住院时间、住院费用、用药费用）；干预前、干预3个月后对比两组用药规范性及用药依从性；评价安全性及满意度。采用t检验、方差分析和χ²检验。结果　观察组住院时间、住院费用、用药费用均低于对照组［（13.45±3.68）d比（15.96±4.01）d、（5 125.44±335.71）元比（5 543.75±340.94）元、（1 483.55±368.94）元比（1 876.43±377.56）元］，差异均有统计学意义（t=2.306、4.371、3.721，均P<0.05）。干预后，观察组不合理用药发生率及用药依从性均优于对照组［16.00%（4/25）比44.00%（11/25）、96.00%（24/25）比72.00%（18/25）］，差异均有统计学意义（均P<0.05）。观察组不良反应发生率低于对照组［12.00%（3/25）比36.00%（9/25）］，且护理满意度高于对照组［96.00%（24/25）比76.00%（19/25）］，差异均有统计学意义（χ²=3.947、4.153，均P<0.05）。结论　临床药师参与的用药管理用于急性脑梗死介入术后，不仅能完善临床对患者的药物管理制度，改善用药效果，降低不合理用药的发生，还能提高患者用药依从性，减少不良反应对疾病康复的影响，且护理满意度较高。

关键词:

急性脑梗死, 临床药师参与的用药管理, 介入术, 用药规范性, 用药依从性, 安全性

Liu Hui, Wang Zhenzhen, Zhao Yafei.

Effects of medication management with clinical pharmacists' participation on medication standardization, compliance, and safety in patients with acute cerebral infarction after intervention [J]. International Medicine and Health Guidance News, 2023, 29(4): 564-568.

刘辉王珍珍赵亚非.

临床药师参与的用药管理对急性脑梗死介入术后患者用药规范性、用药依从性及安全性的影响 [J]. 国际医药卫生导报, 2023, 29(4): 564-568.

References

[1] 郑敏,刘福兰,刘莹莹. 血清AQP4及AQP9水平与急性脑梗死溶栓后出血性转化的相关性分析[J]. 国际医药卫生导报,2021,27(10):1504-1507. DOI:10.3760/cma.j.issn.1007-1245.2021.10.021.
[2] Edwards MD, Hughes TAT. Managing blood pressure in acute cerebral infarction [J]. J Neurol, 2021, 268(6): 2294-2296. DOI:10.1007/s00415-021-10622-6.
[3] 刘润,王小智,于航.亚低温联合右美托咪定对急性脑梗死动脉溶栓术后缺血再灌注损伤影响研究[J].创伤与急危重病医学,2020,8(1):1-3. DOI:10.16048/j.issn.2095-5561. 2020.01.01.
[4] 苏克剑,张乐,万旭,等.按病种分类进行用药医嘱点评模式初探[J]. 中国药房,2019,30(3):310-313. DOI:10.6039/j.issn.1001-0408.2019.03.06.
[5] Paumgartten FJR, Oliveira ACAX. Off label, compassionate and irrational use of medicines in Covid-19 pandemic, health consequences and ethical issues [J]. Cien Saude Colet, 2020,25(9):3413-3419. DOI:10.1590/1413-81232020259.16792020.
[6] 赵晓燕.活血化瘀类中药注射剂治疗缺血性脑梗死的不合理用药现象分析[J].中西医结合心脑血管病杂志,2021,19(11):1923-1926. DOI:10.12102/j.issn.1672-1349. 2021. 11.035.
[7] Alehegn AA, Aklilu RG, Tadesse KA, et al. Assessment of drug use practices using standard WHO indicators in Lumame primary hospital [J]. Drug Healthc Patient Saf, 2021, 13:59-69. DOI:10.2147/DHPS.S286242
[8] 杨乾,郭小彬,斯日古楞,等.临床药师参与肛肠科抗菌药物合理使用管理的效果评价[J].内蒙古医科大学学报,2020,42(3):322-324.
[9] Mbrah AK, Bova C, Jesdale BM, et al. Pain behaviors and pharmacological pain management among newly admitted nursing home residents [J]. Nurs Res, 2021,70(4): 273-280. DOI:10.1097/NNR.0000000000000509.
[10] 颜妍,孟慧杰,胡永芳.泌尿外科临床药师参与抗菌药物规范化管理的效果分析[J].中国医院用药评价与分析,2020,20(7):876-878,881. DOI: 10.14009/j.issn.1672-2124. 2020.07.027.
[11] 黄红,谢懿漫.颈部血管超声联合经颅多普勒超声在老年急性脑梗死患者颈动脉狭窄评估中的应用[J].中国老年学杂志,2022,42(9):2084-2087. DOI:10.3969/j.issn.1005- 9202. 2022.09.012.
[12] 曲俊彦,刘焱斌,吕晓菊. «β内酰胺类抗菌药物皮肤试验指导原则(2021年版)»要点解读[J]. 西部医学,2022,34(1):5-8. DOI:10.3969/j.issn.1672-3511.2022.01.002.
[13] 王燕萍,李德榜,李兴芳,等.急性重症胰腺炎国产美罗培南预防性治疗的临床研究[Z]. 兰州:兰州大学第一医院, 2013.
[14] 许莉,巩忠,李慧英,等.急性脑梗死合并阻塞性睡眠呼吸暂停综合症患者认知功能障碍发生现状及相关危险因素分析[J].卒中与神经疾病,2020,27(3):327-331,340. DOI:10.3969/j.issn.1007-0478.2020.03.010.
[15] 朴淑英.介入取栓联合静脉溶栓治疗脑梗死对患者血管内皮功能和神经功能的影响[J].中国医师杂志,2022,24(4):607-610. DOI:10.3760/cma.j.cn431274-20210302- 00248.
[16] 曹光宇,罗勇. 单纯静脉溶栓与静脉溶栓联合血管内介入治疗对急性缺血性脑血管病的临床疗效比较[J]. 中华老年心脑血管病杂志,2020,22(4):402-405.DOI:10.3969/j.issn.1009-0126.2020.04.017.
[17] 付虹,戎有和,王璐.2017-2018年江苏省中医院脑梗死住院患者使用活血化瘀类中药注射剂合理性评价[J].现代药物与临床,2020,35(1):154-159. DOI:10.7501/j.issn. 1674-5515. 2020.01.032.
[18] 刘秀兰,刘异,裘琳. 药师审方对静脉药物集中调配中心抗肿瘤药物不合理医嘱干预分析[J].医药导报,2021,40(10):1423-1426. DOI:10.3870/j.issn.1004-0781.2021.10.023.
[19] 肖瑛.1766例住院患者注射用血塞通合理用药分析[J].中国药业,2019,28(11):102-104. DOI:10.3969/j.issn. 1006-4931.2019.11.032.
[20] 张楠,夏文斌,杨慧鹃,等.DRGs付费背景下临床药师参与临床路径合理用药管理模式探讨[J].中国药事,2022,36(2):194-202. DOI: 10.16153/j.1002-7777.2022.02.012.
[21] 聂淑华,晏彩霞. 执业药师的职业特征和职业能力分析[J] 药品评价,2020,17(18):8-12. DOI:10.3969/j.issn. 1672-2809.2020.18.003.
[22] 于蕾,李梦岚,周长凤.临床药师参与慢性阻塞性肺疾病急性加重临床路径合理用药研究[J].中华医院管理杂志,2020,36(z2):53-55. DOI:10.3760/cma.j.issn.1000-6672. 2020.z2.021.
[23] 赵明琴,粟珊,陈乾,等.临床药师实施临床路径合理用药监管效果评价[J]. 中国药业,2021,30(7):90-93. DOI:10.3969/j.issn.1006-4931.2021.07.026.
[24] 王云龙.临床药师参与化疗所致恶心、呕吐患者合理用药管理的成效分析[J]. 药学服务与研究,2020,20(4):306-309. DOI:10.5428/pcar20200416.
[25] 古艳婷,李悦,王艳春.临床药师对静脉用药调配中心补充性肠外营养不合理医嘱审核的实践与分析[J].中国医院用药评价与分析,2020,20(8):1005-1008. DOI:10.14009/j.issn.1672-2124.2020.08.029.
[26] 梅玉虹,田海玉,周戈耀,等.住院患者视角下三甲医院临床药学服务开展现状和效果的影响因素研究[J].中国药事,2022,36(2):185-193. DOI:10.16153/j.1002-7777. 2022.02.011.
[27] 姚慧娟,杨宇,陆晓彤,等.抗凝药师参与门诊患者华法林用药管理的实践案例分析[J].药学服务与研究,2021,21(5): 374-377. DOI:10.5428/pcar20210512.
[28] 张晅,陈春玲.临床药师参与关节外科患者疼痛管理的工作模式构建及药学监护实践[J].中南药学,2021,19(1):133-136. DOI:10.7539/j.issn.1672-2981.2021.01.026.
[29] 栗芳,甘梦月,王维,等.临床药师主导的抗菌药物管理模式对妇科围手术期合理用药的影响[J].临床药物治疗杂志,2022,20(6):85-88. DOI:10.3969/j.issn.1672-3384. 2022.06.017.
[30] 王静,陈伯华,殷晓芹,等.临床药师参与骨科围术期2型糖尿病患者血糖管理的实践与效果分析[J].实用药物与临床,2020,23(3):268-271. DOI:10.14053/j.cnki.ppcr. 202003018.